BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SenzaGen - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SenzaGen
X-ORIGINAL-URL:https://senzagen.com
X-WR-CALDESC:Events for SenzaGen
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200617
DTEND;VALUE=DATE:20200618
DTSTAMP:20200603T061943Z
CREATED:20200602T155406Z
LAST-MODIFIED:20200603T061943Z
UID:22722-1592352000-1592438399@senzagen.com
SUMMARY:Web-based launch: The NEW GARDskin Dose-Response
DESCRIPTION:If you’re interested in quantitative potency assessment of your product\, listen in and learn how GARDskin Dose-Response threshold concentrations can be linked to LLNA´s EC3 values and human sensitizing potency. \n\nWhat You Will Learn\nIn this webinar\, attendees will gain insights into: \n\nHow GARDskin Dose-Response studies provide information to establish safety thresholds for different substances.\nHow the threshold concentrations correlate with LLNA’s EC3 values and human sensitizing potency.\nExamples of how the readout can be used depending on the customer specific needs.\n\n  \n \nFeatured Speaker\n \nAndy Forreryd\, PhD\, SenzaGen AB \nHigh information\, high accuracy\nThe GARD tests are developed by combining genomic data from a relevant human cell type with machine learning to create a prediction model for identification of chemical sensitizers. This holistic\, cell-based\, high-information approach provides prediction accuracy exceeding 90% for skin sensitization. \nWith its high accuracy\, demonstrated human relevance and broad applicability\, the GARD assay platform can support your specific test requirements.
URL:https://senzagen.com/event/web-based-launch-the-new-gardskin-dose-response/
LOCATION:4.00pm CEST | 10.00am EDT
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2020/06/17june_Banner_Linkedin.png
END:VEVENT
END:VCALENDAR